Evidence map›Paper›PMID 40621694›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2026

Monocyte-Derived Macrophages-Synovial Fibroblasts Crosstalk Unravels Oncostatin Signaling Network as a Driver of Synovitis in Osteoarthritis.

Damien Laouteouet, Olivier Bortolotti, Léa Marineche, Nicole Hannemann, Manon Chambon, Yaël Glasson, Anne-Sophie Dumé, Julien De Lima, Maud Fournial, Dylan Touchet and 9 more

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Damien LaouteouetInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.ORCID https://orcid.org/0000-0001-8682-3080
Olivier BortolottiInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.ORCID https://orcid.org/0000-0002-3669-8215
Léa MarinecheInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.
Nicole HannemannInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.
Manon ChambonInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.
Yaël GlassonSpatial Imaging Mass Cytometry and Transcriptomic facility, Montpellier Cancer Research Institute, Paris Brain Institute, University of Montpellier, INSERM, Montpellier, France.
Anne-Sophie DuméSpatial Imaging Mass Cytometry and Transcriptomic facility, Montpellier Cancer Research Institute, Paris Brain Institute, University of Montpellier, INSERM, Montpellier, France.
Julien De LimaNantes Université, ONIRIS, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, UMR, Nantes, France.
Maud FournialRAM-INM, University of Montpellier, INSERM, Montpellier, France.
Dylan TouchetRAM-INM, University of Montpellier, INSERM, Montpellier, France.
Dany SéveracMontpellier GenomiX, University of Montpellier, CNRS, INSERM, Montpellier, France.
Felicia LecciaInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.
Christophe DuperrayInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.
Henri-Alexandre MichaudSpatial Imaging Mass Cytometry and Transcriptomic facility, Montpellier Cancer Research Institute, Paris Brain Institute, University of Montpellier, INSERM, Montpellier, France.
Farida DjouadInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.ORCID https://orcid.org/0000-0001-8248-6822
Benoît Le GoffNantes Université, ONIRIS, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, UMR, Nantes, France.
Frédéric BlanchardNantes Université, ONIRIS, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, UMR, Nantes, France.
Florence ApparaillyInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.
Gabriel CourtiesInstitute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, Montpellier, France.ORCID https://orcid.org/0000-0002-0003-7407

Funding

Agence Nationale de la Recherche ANR-18-CE14-0042-01Agence Nationale de la Recherche ANR-21-CE14-0077-01
6 · The paper itself

Abstract

objectiveOsteoarthritis (OA) is a debilitating joint disease that is characterized by cartilage degradation, synovial inflammation, and pain. Macrophages have been implicated in OA pathology, but the origins and functions of diverse macrophage subsets seeding the synovial joint tissue remain incompletely understood. This study investigates macrophage heterogeneity, ontogeny, fate, and communication with stromal niche cells in OA.

methodsSingle-cell RNA sequencing was employed on synovial cells isolated from mice with collagenase-induced OA (CiOA) and CD14

resultsThree macrophage subsets with distinct gene signatures and origins were identified in CiOA, including contributions to synovial inflammation and tissue remodeling. Fate mapping via CCR2-creER and CX3CR1-creER mice revealed the expansion of monocyte-derived TIM4

conclusionOur study provides insights into macrophage subsets and their interplay with the joint microenvironment, bridging the gap between their origins, transcriptomic profiles, and roles in OA. Specifically, the OSM/OSMR axis represents a pivotal mechanism in recruited macrophage-fibroblast crosstalk, offering potential targets for novel biomarkers and therapies to manage OA-related synovitis.

Identifiers

PMID40621694
PMCPMC12854009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.